🇪🇺 Infliximab [infliximab biosimilar 3] in European Union

Infliximab [infliximab biosimilar 3] (infliximab-infliximab-biosimilar-3) regulatory status in European Union.

Marketing authorisation

EMA

  • Local brand name: Infliximab [infliximab biosimilar 3]
  • Status: approved

Infliximab [infliximab biosimilar 3] in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Infliximab [infliximab biosimilar 3] approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Infliximab [infliximab biosimilar 3] in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.